Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 4, 2009, Pages 395-400

  Pietrasik, Grzegorz ^a   Goldenberg, Ilan ^a   McNitt, Scott ^a   Polonsky, Bronislava ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Beta adrenergic blockers; Heart failure; Implantable cardioverter defibrillator; Renin angiotensin system; Sudden death

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; LISINOPRIL; METOPROLOL;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 63449083691     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01333.x     Document Type: Article

References (30)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Klein H, Levine JH, Saksena S, Waldo AL, Wilder D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators : Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 335 : 1933 1940.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trail (SCD-HeFT) Investigators : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
4. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS, for the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators : Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006 113 : 2810 2817.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De arco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM : Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
6. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michi K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr., Adams CD, Anderson JL, Faxon DP, Fuster V, Halperun JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B American college of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Socitey for Heart and Lung Transplantation; Heart Rhythm Society: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005 112 : e154.
7. Kaplan EL, Meier P : Non-parametric estimation from incomplete observations. J Am Stat Association 1958 53 : 457 481.
8. Mantel NBD : Evaluation of response-time data involving transient states: An illustration using heart transplant data. J AM Stat Assoc 1974 69 : 81 86.
9. Cox DR : Regression models and life-tables. J R Stat Soc B 1972 34 : 187 220.
10. The CONSENSUS (Cooperative North Scandinavian Enalapril Survival Study) Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987 316 : 1429 1435.
11. The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 325 : 293 302.
12. Gradus-Pizlo I : How to improve delivery of care in patients with heart failure. Cardiol J 2007 14 : 521 522.
13. The SOLVD Investigators : Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992 327 : 685 691.
14. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC : The SAVE Investigators : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992 327 : 669 677.
15. Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ : Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the studies of left ventricular dysfunction. J Am Coll Cardiol 1999 33 : 916 923.
16. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P, MERIT-HF Study Group : Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 2000 283 : 1295 1302.
17. The MERIT-HF Study Group (Deedwania, Gottlieb S, Principal Investigators, USA) : Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999 353 : 2001 2007.
18. CIBIS-II Investigators and Committees : The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial. Lancet 1999 353 : 9 13.
19. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, U.S. Carvedilol Heart Failure Study Group : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 334 : 1349 1355.
20. Cohn JN : Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 1995 91 : 2504 2507.
21. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S : Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990 82 : 1724 1729.
22. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T : Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984 311 : 819 823.
23. Levine JH, Mellits ED, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LS : Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter- defibrillators. Circulation 1991 84 : 558 566.
24. Remme WJ, Riegger G, Hildebrandt P, Komajda M, Jaarsma W, Bobbio M, Soler-Soler J, Scherhag A, Lutiger B, Ryden L : The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodeling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 2004 18 : 57 66.
25. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, Hall WJ, Andrews M, McNitt S, Daubert JP, MADIT-II Research Group : Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005 96 : 691 695.
26. Fang JC : Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure. Does it matter who goes first? Circulation 2005 112 : 2380 2382.
27. Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, Ponikowski P, Skene A, van de Ven L, Verkenne P, Lechat P, CIBIS III Investigators : Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: Results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005 112 : 2426 2435.
28. Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R : Impact of initiating carvedilol before angiotensin- converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol 2004 44 : 1825 1830.
29. Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reitner MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MA, Akiyama T, Baessler C, Anderson JL : Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia. J Am Coll Cardiol 1999 34 : 325 333.
30. Ellison KE, Hafley GE, Hickey K, Kellen J, Coromilas J, Stein KM, Lee KL, Buxton AE, for the MUSTT Investigators : Effect of β-blocking therapy on outcome in the Multicenter Unsustained Tachycardia Trial (MUSTT). Circulation 2002 346 : 877 883.